Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Biomarkers Stories

2014-03-04 16:17:56

NUS researchers create first highly sensitive small molecule fluorescence probe to evaluate potential risk for Parkinson's disease and monitor its progression A team of researchers from National University of Singapore (NUS) have created the first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual's potential risk for Parkinson's disease. The highly sensitive fluorescence probe can detect with high precision the activity...

2014-03-03 08:30:49

Symposium Highlights New Biomarkers for AKI Risk Assessment SAN DIEGO, March 3, 2014 /PRNewswire/ -- Leading critical care experts will discuss biomarkers for risk assessment of acute kidney injury (AKI) at an educational symposium to be held at the19(th) International Conference on Advances In Critical Care - CRRT 2014 in San Diego. The symposium, "New AKI Biomarkers: A Revolution in Risk Assessment," will be held on Thursday, March 6, 2014, from 12:40 p.m. to 2:00 p.m. local time and is...

2014-02-27 08:29:54

Novel Prognostic Test Is Designed to Guide Optimal Decision-Making at Diagnosis CAMBRIDGE, Mass., Feb. 27, 2014 /PRNewswire/ -- Metamark Genetics, Inc. today announced that its Cambridge, Mass. laboratory has been licensed for the highest level of clinical testing in the use of ProMark(TM), the company's prognostic assay to guide the medical management of patients with prostate cancer. The licensure by the State of Massachusetts for "high-complexity testing" establishes the...

2014-02-26 23:29:43

Cambridge Biomedical Inc announces contract with major biotech for PK/PD biomarker assay development for the detection of phosphorylated histones utilizing Flow Cytometry. Boston, MA (PRWEB) February 26, 2014 Cambridge Biomedical Inc announces contract with major biotech for PK/PD biomarker assay development for the detection of phosphorylated histones utilizing Flow Cytometry. This technique also has many other applications for the detection of genetic damage caused by cytotoxic chemical...

2014-02-26 23:28:26

OMICS Group announces its 5th International Conference on Biomarkers and Clinical Research on April 15-17, 2014 at the University of Oxford with a theme - Diagnostic significance of the therapeutic bio-clinical molecule Henderson, Nevada (PRWEB) February 26, 2014 OMICS Group International is one of the best open access journals publishers and a world-class scientific event organizer. OMICS Group International hosts more than 350 open access peer-reviewed journals and organizes around 100...

Improving Cancer Diagnosis Rates With New Paper Test Strip
2014-02-25 13:37:50

Lee Rannals for redOrbit.com - Your Universe Online Engineers at the Massachusetts Institute of Technology (MIT) have developed a paper test that could improve cancer diagnosis rates. Cancer mortality rates can be drastically reduced with early detection, but some of these methods, such as mammography and colonoscopy, are unable to be used in developing nations. Cancer rates in these countries now account for 70 percent of mortality around the world, so a new method to detect the...

2014-02-20 08:32:23

DUBLIN, Feb. 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/sr9sgc/cancer_molecular ) has announced the addition of the "Cancer Molecular Diagnostics: Suppliers Market Report 2014" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Cancer diagnostics is one of the most dynamic medical fields, reflecting efforts to translate new advances in cancer into improved tests and treatments. Increasingly, researchers and...

2014-02-18 08:31:03

- Statistically significant and durable reductions in troponin and NT-proBNP SAN DIEGO, Feb. 18, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced new data from its randomized, placebo-controlled, nonclinical study of MST-188 (low dose and high dose) in a model of chronic heart failure. The Company previously announced that a single, two-hour infusion of MST-188 improved left ventricular systolic function that was significant immediately (at the end of MST-188...

2014-02-11 08:32:18

US and Japanese patents cover the Company's whole slide imaging and analysis platform, which simultaneously measures tumor, immune, and stromal cells, processes, and biomarkers on a single specimen PITTSBURGH, Feb. 11, 2014 /PRNewswire/ -- Cernostics, a diagnostics company delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that the United States Patent and Trademark Office has issued two patents, US Patent 8,114,615 and US Patent...

2014-02-07 08:24:01

DUBLIN, Feb. 7, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/bt6gxm/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts (2013 - 2018)" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are...